Genfit S.A.
Genfit S.A. (GNFT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gnft · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Genfit S.A. (GNFT) measures how much investors pay for each dollar of the company's trailing earnings. GNFT's current PE ratio of N/A is calculated by dividing its stock price of $8.95 by its TTM earnings per share of -$1.72.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%121.2x
MedianQ3 · 75%595.6x
Max
At N/A, GNFT's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Genfit S.A.You GNFT | $446M | N/A | — | -$1.72 |
 Armata Pharmaceuticals, Inc. ARMP | $274M | N/A | — | -$4.80 |
 Eupraxia Pharmaceuticals Inc. EPRX | $204M | N/A | — | -$1.35 |
 Inventiva S.A. IVA | $203M | N/A | — | -$1.82 |
 Invivyd, Inc. IVVD | $135M | N/A | — | -$0.30 |
 MediWound Ltd. MDWD | $154M | N/A | — | -$2.10 |
 Neonc Technologies Holdings, Inc. NTHI | $91M | N/A | — | -$3.23 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 119.75x | $0.03 | — | |
2023-12-31 FY2023 | — | $-0.58 | — | |
2022-12-31 FY2022 | — | $-0.48 | — | |
2021-12-31 FY2021 | 2.92x | $1.50 | — | |
2020-12-31 FY2020 | — | $-2.60 | — | |
2019-12-31 FY2019 | — | $-1.76 | — | |
2018-12-31 FY2018 | — | $-2.55 | — | |
2017-12-31 FY2017 | — | $-1.88 | — | |
2016-12-31 FY2016 | — | $-1.28 | — | |
2015-12-31 FY2015 | — | $-0.69 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Genfit S.A. (GNFT) measures how much investors pay for each dollar of the company's trailing earnings. GNFT's current PE ratio of N/A is calculated by dividing its stock price of $8.95 by its TTM earnings per share of -$1.72.
Frequently asked questions
GNFT pe ratio · 6 questionsGNFT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $8.95 and TTM EPS of -$1.72. Data sourced from Financial Modeling Prep via GNFT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Genfit S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09